CROWDSTRIKE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against CrowdStrike Holdings, Inc. - CRWD
CROWDSTRIKE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against CrowdStrike Holdings, Inc. - CRWD
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 30, 2024 to file lead plaintiff applications in a securities class action lawsuit against CrowdStrike Holdings, Inc. (the “Company”) (NasdaqGS: CRWD), if they purchased the Company’s Class A shares between November 29, 2023 and July 29, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Texas.
What You May Do
If you purchased shares of CrowdStrike and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-crwd/ to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by September 30, 2024.
About the Lawsuit
CrowdStrike and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On July 19, 2024, an update pushed by the Company caused global outages for millions of users of Microsoft Windows devices, including financial institutions, airlines, government entities, and corporations, and left users vulnerable to potential hacking threats. On this news, the price of CrowdStrike shares fell $38.09 or 11% to close at $304.96 on July 19, 2024. Then, on July 22, 2024, it was revealed that Congress had called on CEO George Kurtz to testify regarding the catastrophe, and the Company’s stock rating was downgraded by analysts. On this news, the price of CrowdStrike shares fell $41.05 or 13.5% to close at $263.91 on July 22, 2024. Then, on July 29, 2024, news outlets reported that Delta Air Lines had retained noted attorney David Boies to seek damages from the Company following the outages. On this news, the price of CrowdStrike shares fell $25.16 or 10% to close at $233.65 on July 30, 2024.
The case is Plymouth County Retirement Association v. CrowdStrike Holdings, Inc., et al., 24-cv-00857.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana and New Jersey.
To learn more about KSF, you may visit www.ksfcounsel.com.
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
View source version on businesswire.com: https://www.businesswire.com/news/home/20240927145002/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks